1. Home
  2. IMUX vs QRHC Comparison

IMUX vs QRHC Comparison

Compare IMUX & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • QRHC
  • Stock Information
  • Founded
  • IMUX 2016
  • QRHC N/A
  • Country
  • IMUX United States
  • QRHC United States
  • Employees
  • IMUX N/A
  • QRHC N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • QRHC Environmental Services
  • Sector
  • IMUX Health Care
  • QRHC Utilities
  • Exchange
  • IMUX Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • IMUX 94.9M
  • QRHC 92.0M
  • IPO Year
  • IMUX N/A
  • QRHC N/A
  • Fundamental
  • Price
  • IMUX $1.01
  • QRHC $2.49
  • Analyst Decision
  • IMUX Strong Buy
  • QRHC Strong Buy
  • Analyst Count
  • IMUX 6
  • QRHC 2
  • Target Price
  • IMUX $13.20
  • QRHC $12.75
  • AVG Volume (30 Days)
  • IMUX 1.3M
  • QRHC 81.0K
  • Earning Date
  • IMUX 05-20-2025
  • QRHC 05-12-2025
  • Dividend Yield
  • IMUX N/A
  • QRHC N/A
  • EPS Growth
  • IMUX N/A
  • QRHC N/A
  • EPS
  • IMUX N/A
  • QRHC N/A
  • Revenue
  • IMUX N/A
  • QRHC $288,532,000.00
  • Revenue This Year
  • IMUX N/A
  • QRHC $7.55
  • Revenue Next Year
  • IMUX N/A
  • QRHC $7.03
  • P/E Ratio
  • IMUX N/A
  • QRHC N/A
  • Revenue Growth
  • IMUX N/A
  • QRHC 0.05
  • 52 Week Low
  • IMUX $0.83
  • QRHC $1.91
  • 52 Week High
  • IMUX $2.11
  • QRHC $10.51
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 46.64
  • QRHC 48.54
  • Support Level
  • IMUX $0.95
  • QRHC $2.14
  • Resistance Level
  • IMUX $1.22
  • QRHC $2.51
  • Average True Range (ATR)
  • IMUX 0.12
  • QRHC 0.20
  • MACD
  • IMUX -0.01
  • QRHC 0.07
  • Stochastic Oscillator
  • IMUX 16.67
  • QRHC 69.81

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations.

Share on Social Networks: